CN Patent

CN112321505B — 一种伯舒替尼晶型及其制备方法

Assigned to Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd · Expires 2022-08-23 · 4y expired

What this patent protects

本发明提供了一种具有特定晶型生长面的伯舒替尼新晶型I及其制备方法。该新晶型I可通过在乙醇水溶液/水的结晶体系获得，工艺简单，易于操作，适合工业化生产。制得的新晶型I溶解度大、可压性和流动性好，压制成的片剂硬度满足生产要求，不易碎裂，为伯舒替尼新制剂的研究提供了支持。

USPTO Abstract

本发明提供了一种具有特定晶型生长面的伯舒替尼新晶型I及其制备方法。该新晶型I可通过在乙醇水溶液/水的结晶体系获得，工艺简单，易于操作，适合工业化生产。制得的新晶型I溶解度大、可压性和流动性好，压制成的片剂硬度满足生产要求，不易碎裂，为伯舒替尼新制剂的研究提供了支持。

Drugs covered by this patent

Patent Metadata

Patent number
CN112321505B
Jurisdiction
CN
Classification
—
Expires
2022-08-23
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.